SCHEDULE: Artisan Partners Boosts Twist Bioscience Stake to 10.6%

Artisan Partners Asset Management Inc. and its affiliates have reported a 10.6% beneficial ownership stake in Twist Bioscience Corporation, holding 6,410,900 common shares.

Summary

• Artisan Partners Asset Management Inc., along with its affiliated entities Artisan Partners Holdings LP, Artisan Investments GP LLC, and Artisan Partners Limited Partnership, collectively beneficially own 6,410,900 shares of Twist Bioscience Corporation common stock.
• This ownership represents 10.6% of the outstanding common stock, calculated based on 60,360,925 shares outstanding as of July 30, 2025.
• The reporting persons hold shared voting power over 5,303,412 shares and shared dispositive power over 6,410,900 shares.
• The shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Twist Bioscience Corporation.

Sentiment

Score: 7

Explanation: The filing is a factual disclosure of a significant institutional ownership stake. While neutral in tone, the presence of a large, reputable asset manager like Artisan Partners holding a 10.6% stake is generally viewed by the market as a positive signal of confidence in the issuer, hence a slightly positive sentiment score.

Positives

• A major institutional investor, Artisan Partners, holds a significant 10.6% stake, which can be interpreted as a signal of confidence in Twist Bioscience Corporation.

Future Outlook

No forward-looking statements or guidance from Twist Bioscience Corporation were provided in this filing.

Industry Context

Artisan Partners is a prominent global investment management firm. Their significant stake in Twist Bioscience Corporation, a company operating in the biotechnology sector, reflects their investment strategy and interest in the life sciences industry, particularly in areas like synthetic DNA and genomics.

Stakeholder Impact

• Shareholders: Increased institutional ownership by a major asset manager may be viewed positively, potentially signaling confidence and stability in the company's long-term prospects.
• Company (Twist Bioscience): A significant passive institutional stake can contribute to a stable shareholder base, reducing volatility from retail investor sentiment.

Key Dates

Recommendation

The filing indicates a significant, passive institutional stake by Artisan Partners in Twist Bioscience. While this signals confidence from a major asset manager, the filing itself does not provide operational or financial performance data to warrant a 'buy' or 'sell' recommendation. Investors should consider this as a data point on institutional interest and conduct further due diligence on the company's fundamentals before making investment decisions.

Keywords

Twist Bioscience, Artisan Partners, SEC filing, Schedule 13G, beneficial ownership, institutional investment, common stock, biotechnology, synthetic DNA